This agrees with the results of Pagano et al (2006) who found that resistin was higher in NAFLD patients compared to controls.15 Similarly, Jiang et al (2009) found that serum resistin concentrations were significantly increased in patients with NAFLD compared to control subjects.14 This evidence concerns the gene RETN and metabolic dysfunction-associated steatotic liver disease.